ProjectCAIN457ADE15 Pinpoint
Basic data
Title:
CAIN457ADE15 Pinpoint
Duration:
30/10/2020 to 31/12/2022
Abstract / short description:
A randomized, double-blind, multicenter, 24-week study of subcutaneous secukinumab to assess anti-interleukin-17A treatment in plaque psoriasis patients with coexisting non-alcoholic fatty liver disease (pINPOINt)
EUDRACT number: 2019-003168-37
EUDRACT number: 2019-003168-37
Keywords:
psoriasis therapeutics
Psoriasis Therapeutika
psoriasis
Schuppenflechte
Involved staff
Managers
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Faculty of Medicine
University of Tübingen
University of Tübingen
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
The M3 Research Center - Malignom, Metabolome and Microbiome
Non-clinical institutes, Faculty of Medicine
Non-clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Nürnberg, Bayern, Germany